| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |